Goodrx is trading 5.16% up at $3.56, outperforming a broadly weaker market as healthcare stocks attract defensive buying.
- Healthcare ETF XLV is up 1.28% during regular trading, supporting sector-wide momentum.
- No clear company-specific announcement or analyst action dated September 14, 2026 was identified.
- GoodRx’s September 3 launch of its $24.99 Companion Family Plan remains the latest notable company news but does not directly explain today’s move.